EC

EcoR1 Capital Portfolio holdings

AUM $1.69B
This Quarter Return
-9.17%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$749M
AUM Growth
+$749M
Cap. Flow
-$79.3M
Cap. Flow %
-10.59%
Top 10 Hldgs %
75.79%
Holding
46
New
9
Increased
6
Reduced
13
Closed
11
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SURF
26
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$2.2M 0.28% 1,548,888 -763,800 -33% -$1.08M
RUBY
27
DELISTED
Rubius Therapeutics, Inc
RUBY
$2.04M 0.26% 260,152 -203,000 -44% -$1.59M
VCEL icon
28
Vericel Corp
VCEL
$1.83B
$1.98M 0.25% 131,001
IGMS
29
DELISTED
IGM Biosciences
IGMS
$1.78M 0.22% +100,000 New +$1.78M
LRMR icon
30
Larimar Therapeutics
LRMR
$310M
$1.44M 0.18% +1,944,500 New +$1.44M
QNCX icon
31
Quince Therapeutics
QNCX
$85.9M
$1.25M 0.16% +49,993 New +$1.25M
ASMB icon
32
Assembly Biosciences
ASMB
$190M
$950K 0.12% +96,600 New +$950K
AUTL
33
Autolus Therapeutics
AUTL
$399M
$859K 0.11% +69,155 New +$859K
RGLS
34
DELISTED
Regulus Therapeutics
RGLS
$755K 0.1% 1,049,088 -62,022 -6% -$44.6K
UBX
35
DELISTED
Unity Biotechnology
UBX
$314K 0.04% 51,400 -993,100 -95% -$6.07M
CRSP icon
36
CRISPR Therapeutics
CRSP
$4.71B
-1,610,250 Closed -$75.8M
GOSS icon
37
Gossamer Bio
GOSS
$562M
-772,096 Closed -$17.1M
KZR icon
38
Kezar Life Sciences
KZR
$28.9M
-583,293 Closed -$4.5M
MRSN icon
39
Mersana Therapeutics
MRSN
$36.5M
-1,392,231 Closed -$5.64M
RYTM icon
40
Rhythm Pharmaceuticals
RYTM
$6.85B
-223,167 Closed -$4.91M
SYRS
41
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-248,480 Closed -$2.3M
NGM
42
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
-316,900 Closed -$4.64M
GMDA
43
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
-52,120 Closed -$265K
KDNY
44
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-1,761,421 Closed -$2.71M
TCRR
45
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-16,114 Closed -$231K
ARQL
46
DELISTED
Arqule Inc
ARQL
-1,300,000 Closed -$14.3M